Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study-Reference-Cited by-同舟云学术

Prostate Cancer Risks for Male BRCA1 and BRCA2 Mutation Carriers: A Prospective Cohort Study

Published:2020-01 Issue:1 Volume:77 Page:24-35
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Nyberg Tommy^ORCID,Frost Debra,Barrowdale Daniel,Evans D. Gareth,Bancroft Elizabeth,Adlard Julian,Ahmed Munaza,Barwell Julian,Brady Angela F.,Brewer Carole,Cook Jackie,Davidson Rosemarie,Donaldson Alan,Eason Jacqueline,Gregory Helen,Henderson Alex,Izatt Louise,Kennedy M. John,Miller Claire,Morrison Patrick J.,Murray Alex,Ong Kai-Ren,Porteous Mary,Pottinger Caroline,Rogers Mark T.,Side Lucy,Snape Katie,Walker Lisa,Tischkowitz Marc,Eeles Rosalind,Easton Douglas F.,Antoniou Antonis C.

Publisher

Elsevier BV

Subject

Urology

Reference32 articles.

1. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies;Antoniou;Am J Hum Genet,2003

2. Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers;Kuchenbaecker;JAMA,2017

3. The association of BRCA1 and BRCA2 mutations with prostate cancer risk, frequency, and mortality: A meta-analysis;Oh;Prostate,2019

4. Cancer risks in BRCA2 mutation carriers;Breast Cancer Linkage Consortium;J Natl Cancer Inst,1999

5. BRCA mutations and risk of prostate cancer in Ashkenazi Jews;Kirchhoff;Clin Cancer Res,2004

Cited by 150 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of germline mutations in metastatic hormone-sensitive prostate cancer (mHSPC);Urologic Oncology: Seminars and Original Investigations;2024-10

2. Cancer de prostate métastatique résistant à la castration et inhibiteurs de PARP : de la génomique tumorale aux nouvelles associations thérapeutiques;Bulletin du Cancer;2024-09

3. Genetics of prostate cancer: a review of latest evidence;Journal of Medical Genetics;2024-08-13

4. BRCA1, BRCA2, and Associated Cancer Risks and Management for Male Patients;JAMA Oncology;2024-07-25

5. Genomic instability in non–breast or ovarian malignancies of individuals with germline pathogenic variants in BRCA1/2;JNCI: Journal of the National Cancer Institute;2024-07-03